Autism Spectrum Disorder Market

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child?s behavior and development to make a diagnosis. Our report studies the market from 2014-2025, examining programs and medications used to the patient with autism.

Symptoms and Signs

Autism spectrum disorders may manifest during the first year of life but, depending on severity of symptoms, diagnosis may not be clear until school age.

Two main features characterize autism spectrum disorders:

Persistent deficits in social communication and interaction

Restricted, repetitive patterns of behavior, interests, and/or activities

Both of these features must be present at a young age (although they may not be recognized at the time) and must be severe enough to significantly impair the child's ability to function at home, school, or other situations. Manifestations must be more pronounced than expected for the child?s developmental level and adjusted for norms in different cultures.

Autism Spectrum Disorder Market contains market size and forecasts of Autism Spectrum Disorder in Global, including the following market information:

Global Autism Spectrum Disorder Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Autism Spectrum Disorder market was valued at 9275.6 million in 2021 and is projected to reach US$ 11610 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Autistic Disorder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Autism Spectrum Disorder include Otsuka, AstraZeneca, Pfizer, Eli Lilly and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autism Spectrum Disorder companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Autism Spectrum Disorder Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Autism Spectrum Disorder Market Segment Percentages, by Type, 2021 (%)

Autistic Disorder

Asperger Syndrome

Childhood Disintegrative Disorder

Others

Global Autism Spectrum Disorder Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Autism Spectrum Disorder Market Segment Percentages, by Application, 2021 (%)

Children and Teenagers

Adults

Global Autism Spectrum Disorder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Autism Spectrum Disorder Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Autism Spectrum Disorder revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Autism Spectrum Disorder revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Otsuka

AstraZeneca

Pfizer

Eli Lilly

Johnson & Johnson